Search - tctmd.com

Displaying 61 - 78 of 78

Sort: Relevancy | Date

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Todd Neale

May 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

Shelley Wood

April 30, 2024

Podcast Rox Heart Radio

Rox Heart Radio: DanGer Shock

April 11, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

L.A. McKeown

February 06, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

Shelley Wood

January 01, 2024

Partner Content

The Clinical PE Story: PEERLESS RCT Comparing FlowTriever to CDT

December 6, 2024

Advertisement

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Statins Might Help in HFpEF—Even in the Absence of ASCVD

May 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for April 2024

Rox Heart Radio: DanGer Shock

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

April 2024 Dispatch for the CV Team

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

Patients With CKD Remain Underrepresented in Trials of CV Meds

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

The Biggest News of 2023: TCTMD’s Top 10

The Clinical PE Story: PEERLESS RCT Comparing FlowTriever to CDT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content